Colleen Delaney, MD, MSc (she/her/hers)

Founder and Chief Scientific Officer
Deverra Therapeutics
seattle, Washington, United States

Presentation(s):

• AM24-MN-41-L - The AABB Cellular Starting Material Forum: From Consent to Characterization - Enhancing Allogeneic Donor Practices

  Monday, October 21, 2024
  9:30 AM - 11:00 AM  

  Disclosure(s): Coeptis Therapeutics: Full-time/Part-time Employee or Owner (Ongoing); Deverra Therapeutics: Full-time/Part-time Employee or Owner (Ongoing), Stock Shareholder (self-managed) (Ongoing)

• AM24-MN-34-L - Mechanisms and Technologies Towards Expanding Hematopoietic Stem Cells for Transplantation

  Monday, October 21, 2024
  5:30 PM - 6:30 PM  

  Disclosure(s): Coeptis Therapeutics: Full-time/Part-time Employee or Owner (Ongoing); Deverra Therapeutics: Full-time/Part-time Employee or Owner (Ongoing), Stock Shareholder (self-managed) (Ongoing)